Tianyin Pharmaceutical Co., Inc. - TPI

Tianyin Pharmaceutical Co., Inc. (TPI)
http://www.tianyinpharma.com
Coverage: October 3, 2009 - October 3, 2010
Featured: October 3, 2009

Latest Newsletter Editions

spacer
Sat, May 22, 2010 @ 02:05 pm
There was a little relief rally on Friday after a fairly wicked week in the markets. Thursday's giant sell down felt like a "cash at any cost" down draft, with almost no regard for value. That's fine with me. These kinds of emotional, momentum driven markets present opportunities for those with the...
Tue, May 18, 2010 @ 10:05 am
A Busy Day- Comments on a Bunch of Stuff Frankly, it's a bit annoying. I wish these smaller companies could get their quarterly numbers out over a few week period in time, instead of all in one or two days at the absolute deadline. I just can't get quality commentary out fast enough for investors to...
Mon, Feb 1, 2010 @ 03:02 pm
Nothing Like a Cool $200 Million You might wonder who's got the cool $200 million, and what it has to do with today's edition of the OTC Journal. Remember my short term trading idea?- TapImmune (OTC BB: TPIV) I said some positive developments would start to roll their way, and today's post close news...
Wed, Jan 27, 2010 @ 09:01 am
Two Beat Downs; Stand By I just wanted to publish a couple of quick notes on two stocks I've been covering and have made comments on recently. First on China Recycling Energy (CREG)- someone is selling the stock fairly ruthlessly with little regard for price. It started two days ago, and the stock is...
Thu, Jan 21, 2010 @ 01:01 pm
How The Immune System Fights Disease Our bodies have a miraculous capability. Our Immune System, through a complex network of cells and chemicals, has the ability to identify bad stuff and rapidly recruit an army to attack foreign invaders and kill them. T-Cells are the circus ring masters. The T-Cells...

Click Here For More Newsletters on TPI

spacer

Latest Blog Entries

spacer

Quote Data

spacer
Last Trade: 0.57 Bid: 0.0000
Last Size: 0 Ask: 0.0000
Trade Time: 4:00pm Bid x Ask Size: N/A
Change: down arrow -0.0198 (-3.36%) Day's Range: 0.57 - 0.61
Prev Close: 0.5898 52wk Range: 0.43 - 1.37
Open: 0.6001 P/E (ttm): N/A
Volume: 22,439 EPS (ttm): -0.009
spacer [Chart]

Business Summary

spacer
Tianyin Pharmaceutical Co., Inc. engages in the development, manufacture, marketing, and sale of modernized traditional Chinese medicines and other pharmaceuticals in the People’s Republic of China. The company’s products are intended to address various medical needs in the therapeutic areas spanning internal medicines, gynecology, hepatology, otolaryngology, urology, neurology, gastroenterology, orthopedics, dermatology, and pediatrics. It manufactures a portfolio of 39 modernized traditional Chinese medicines and pharmaceuticals, and has a pipeline of 17 products, which are pending regulatory approvals with the China State Food and Drug Administration. The company was founded in 1994 and is based in Chengdu, the People’s Republic of China.

Disclosure

spacer
The OTC Journal has received no compensation for coverage of Tianyin Pharmaceutical Co., Inc.

Recent News Headlines

spacer
TIANYIN PHARMACEUTICAL CO., INC. Files SEC form 8-K/A, Change in Directors or Principal Officers
Mon, 27 Oct 2014 10:02:45 GMT
TPI's QLF Updates on its GMP Certification Progress
Thu, 23 Oct 2014 12:34:00 GMT
[PR Newswire] - CHENGDU, China, Oct. 23, 2014 /PRNewswire/ -- Tianyin Pharmaceutical Co., Inc. (NYSE Amex: TPI), a pharmaceutical company that specializes in patented biopharmaceutical, modernized traditional Chinese medicine (mTCM), branded generics and active pharmaceutical ingredients (API) today updates that its Qionglai Facility (QLF) Good Manufacturing Practice (GMP) certification by the China Food & Drug Administration's (CFDA) is on schedule. The Company forecasts that the QLF may receive its formal certification as early as November 2014. TPI is currently preparing the smooth transition of production capacity from the current Longquan facility to the new QLF immediately following the official issuance of GMP certificate.
TIANYIN PHARMACEUTICAL CO., INC. Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Ru
Tue, 21 Oct 2014 18:21:40 GMT
Tianyin Pharmaceutical Received Notices of Non-Compliance from NYSE MKT
Tue, 21 Oct 2014 18:09:00 GMT
[PR Newswire] - CHENGDU, China, Oct. 21, 2014 /PRNewswire/ -- Tianyin Pharmaceutical Inc. (NYSE MKT: TPI, the "Company"), a pharmaceutical company that specializes in the development and sale of patented biopharmaceutical medicine, modernized traditional Chinese medicine (TCM), branded generics and active pharmaceutical ingredients (API), today reported that, on October 15, 2014, it received a notice from the NYSE MKT Staff indicating that the Company is below certain of the continued listing standards of the NYSE MKT (the "Exchange") as set forth in Sections 134 and 1101 of the NYSE MKT Company Guide, due to the delay in filing its Annual Report on Form 10-K for fiscal year ended June 30, 2014 (the "2014 Form 10-K") beyond the extended filing due date of October 14, 2014. Under NYSE MKT rules, until the Company files its Form 10-K, its common stock will remain listed on the NYSE MKT under the symbol "TPI," but will be assigned an ".LF" indicator to signify late filing status. Currently the Company is working diligently with the auditor to finish the audit and complete the 2014 10-K, and expect to file the 2014 Form 10-K by October 29, 2014.
TIANYIN PHARMACEUTICAL CO., INC. Files SEC form 8-K, Change in Directors or Principal Officers
Thu, 16 Oct 2014 14:09:58 GMT
TIANYIN PHARMACEUTICAL CO., INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
Wed, 15 Oct 2014 17:13:33 GMT
Tianyin Pharmaceutical Provides Update on Filing of Form 10-K for Fiscal Year Ended June 30, 2014
Wed, 15 Oct 2014 15:33:00 GMT
[PR Newswire] - CHENGDU, China, Oct. 15, 2014 /PRNewswire/ -- Tianyin Pharmaceutical Inc. (NYSE MKT: TPI, the "Company"), a pharmaceutical company that specializes in the development and sale of patented biopharmaceutical ...
TPI's QLF Completes GMP site inspection by CFDA
Mon, 29 Sep 2014 13:54:00 GMT
[PR Newswire] - CHENGDU, China, Sept. 29, 2014 /PRNewswire/ -- Tianyin Pharmaceutical Co., Inc. (NYSE Amex: TPI), a pharmaceutical company that specializes in patented biopharmaceutical, modernized traditional Chinese medicine (mTCM), branded generics and active pharmaceutical ingredients (API), today announced that its Qionglai Facility (QLF) has successfully completed the official site visit by the China Food & Drug Administration's (CFDA) for its Good Manufacturing Practice (GMP) certification. In early September 2014, the Company has submitted the GMP dataset for CFDA review, following final rounds of test runs at QLF following months of preparation and production optimization.
JCM Applies for Azithromycin API Import Certificate at India
Tue, 09 Sep 2014 13:00:00 GMT
[PR Newswire] - CHENGDU, China, Sept. 9, 2014 /PRNewswire/ -- Tianyin Pharmaceutical Inc. (NYSE Amex: TPI), a pharmaceutical company that specializes in the development and sale of patented biopharmaceutical medicine, ...
TPI Submits Dataset for GMP Inspection at Qionglai Facility (QLF)
Thu, 28 Aug 2014 16:10:00 GMT
[PR Newswire] - CHENGDU, China, Aug. 28, 2014 /PRNewswire/ -- Tianyin Pharmaceutical Co., Inc. (NYSE Amex: TPI), a pharmaceutical company that specializes in patented biopharmaceutical, modernized traditional Chinese ...
Qionglai Facility (QLF) Schedules September for GMP Examination
Mon, 18 Aug 2014 12:30:00 GMT
[PR Newswire] - CHENGDU, China, Aug. 18, 2014 /PRNewswire/ -- Tianyin Pharmaceutical Co., Inc. (NYSE MKT: TPI), a pharmaceutical company that specializes in patented biopharmaceutical, modernized traditional Chinese medicine (mTCM), branded generics and active pharmaceutical ingredients (API) today provided further updates for the GMP certification regarding the Company's Qionglai Facility (QLF). Through a series of testing runs using various traditional Chinese medicine (TCM) raw materials at individual production lines, QLF has been preparing for the final GMP examination by the provincial China Food and Drug Administration (CFDA).
Testing Runs Progress Updates for TPI's Qionglai Facility
Mon, 04 Aug 2014 07:11:00 GMT
[PR Newswire] - CHENGDU, China, Aug. 4, 2014 /PRNewswire/ -- Tianyin Pharmaceutical Co., Inc. (NYSE Amex: TPI), a pharmaceutical company that specializes in patented biopharmaceutical, modernized traditional Chinese medicine ...
TPI Targets Early August 2014 to Start Qionglai Facility (QLF) GMP Inspection
Mon, 14 Jul 2014 13:51:00 GMT
[PR Newswire] - CHENGDU,China, July 14, 2014 /PRNewswire/ -- Tianyin Pharmaceutical Co., Inc. (NYSE Amex: TPI), a pharmaceutical company that specializes in patented biopharmaceutical, modernized traditional Chinese medicine (mTCM), branded generics and active pharmaceutical ingredients (API) today provided updates regarding the Company's Qionglai Facility (QLF). QLF, after the completion of its construction followed by the equipment installation, has conducted a series of procedures and tests that prepare the facility for GMP certification by the China Food & Drug Administration (CFDA).
TIANYIN PHARMACEUTICAL CO., INC. Files SEC form 8-K/A, Other Events
Tue, 08 Jul 2014 10:06:52 GMT
TPI Receives GMP for Tablets Formulation in Early July
Mon, 07 Jul 2014 12:53:00 GMT
[PR Newswire] - CHENGDU, China, July 7, 2014 /PRNewswire/ -- Tianyin Pharmaceutical Inc. (NYSE Amex: TPI), a pharmaceutical company that specializes in the development and sale of patented biopharmaceutical medicine, ...
TPI Attends CPhI to Facilitate Azithromycin API Export Business
Mon, 30 Jun 2014 00:08:00 GMT
[PR Newswire] - CHENGDU, China, June 29, 2014 /PRNewswire/ -- Tianyin Pharmaceutical Inc. (NYSE Amex: TPI), a pharmaceutical company that specializes in the development and sale of patented biopharmaceutical medicine, ...
TIANYIN PHARMACEUTICAL CO., INC. Files SEC form 8-K/A, Other Events
Mon, 23 Jun 2014 12:58:54 GMT
TIANYIN PHARMACEUTICAL CO., INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders
Wed, 28 May 2014 21:12:27 GMT
TIANYIN PHARMACEUTICAL CO., INC. Financials
Fri, 23 May 2014 17:04:24 GMT
TIANYIN PHARMACEUTICAL CO., INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
Mon, 19 May 2014 20:50:32 GMT